William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 24,665 shares at $20.30 ($501K) on 2023-08-24, disclosed to the SEC on 2023-08-25.
Open-market sale of $501k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.30 | 12,332 | $250K | 50.0% |
| 2 | $20.30 | 12,332 | $250K | 50.0% |
| 3 | $20.89 | 1 | $21 | 0.0% |
| Total | $20.30 avg | 24,665 | $501K | 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |